Skip to main content
OpenTrials

Clinical trial condition

Shock, Septic

Explore clinical trials studying Shock, Septic. Study availability and eligibility vary by location and protocol.

705 public trials 114 recruiting studies
Refine in advanced search Browse all conditions

Shock, Septic trial results

Completed

Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock

NCT00148278

Conditions
Infections, Inflammation, Pathologic Processes, +7 more
Locations
  • Réanimation Médicale - Hôpital Louis Mourier Colombes, France
  • Réanimation Polyvalente - Hôpital de Corbeil Corbeil, France
  • Service de Réanimation Médicale - Hôpital Poincaré Garches, France
  • Réanimation Médicale - Hôpital André Mignot Le Chesnay, France
View all 15 locations
View Trial Details
Completed

Fluid Resuscitation in Early Septic Shock

NCT00819416

Conditions
Infections, Inflammation, Pathologic Processes, +7 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Winnipeg Health Sciences Center Winnipeg, Manitoba, Canada
  • Halifax Capital Health Center Halifax, Nova Scotia, Canada
  • Hamilton General Hospital Hamilton, Ontario, Canada
View Trial Details
Completed

Dopamine and Norepinephrine in Shock Patients

NCT00314704

Conditions
Cardiovascular Diseases, Heart Diseases, Hypotension, +15 more
Locations
  • University Hospital of Vienna Vienna, Austria
  • CHU Saint Pierre Brussels, Belgium
  • CHU Brugmann Brussels, Belgium
  • HIS Ixelles Brussels, Belgium
View Trial Details
Completed

The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis

NCT00329680

Conditions
Infections, Inflammation, Pathologic Processes, +7 more
Locations
  • Hospital Fernandes Távora - Adult Intensive Care Unit Fortaleza, Ceará, Brazil
  • Hospital Português - Real Sociedade Portuguesa 16 de Setembro Salvador, Estado de Bahia, Brazil
  • Hospital Salvador Salvador, Estado de Bahia, Brazil
  • Hospital Santa Luzia Brasília, Federal District, Brazil
View Trial Details
Completed

Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock

NCT00279214

Conditions
Infections, Inflammation, Pathologic Processes, +6 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Camden, New Jersey, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Akron, Ohio, United States
View Trial Details

Related conditions